Replies to post #209448 on Biotech Values

[DewDiligence]

LJPC -6%/AH on $115M* offering with unspecified terms:

http://finance.yahoo.com/news/la-jolla-pharmaceutical-company-announces-200100059.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

FDA approves LJPC’s Giapreza for hypotension:

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm590249.htm

The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.